| Date | Time | Source | Announcement |
|---|---|---|---|
| 23 May 2023 | 04:00 PM | Net Asset Value(s) | |
| 19 May 2023 | 06:15 PM | Transaction in Own Shares | |
| 19 May 2023 | 07:00 AM | Update on Investment | |
| 18 May 2023 | 06:15 PM | Transaction in Own Shares | |
| 16 May 2023 | 03:40 PM | Director/PDMR Shareholding | |
| 11 May 2023 | 07:00 AM | NEW INVESTMENT OF UP TO US$137.5 MILLION | |
| 09 May 2023 | 06:15 PM | Transaction in Own Shares | |
| 05 May 2023 | 06:15 PM | Transaction in Own Shares | |
| 02 May 2023 | 06:15 PM | Transaction in Own Shares | |
| 02 May 2023 | 01:26 PM | Total Voting Rights | |
| 25 Apr 2023 | 04:00 PM | Net Asset Value(s) and Monthly Factsheet |
BioPharma Credit is a specialist British investment trust that provides debt capital to the life sciences industry. It generates income by investing in loans secured by royalties and cash flows from approved medical products.
BioPharma Credit share price listed at USD1 in 2017.